DEUTSCHE BANK AG\ - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 45 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q2 2019$198,000
-90.9%
217,000
-90.9%
0.00%
-100.0%
Q1 2019$2,185,000
-7.3%
2,372,000
-9.2%
0.00%
-50.0%
Q4 2018$2,356,000
+26.0%
2,612,000
+30.6%
0.00%
+100.0%
Q3 2018$1,870,000
+0.9%
2,000,0000.0%0.00%0.0%
Q2 2018$1,853,000
+5.8%
2,000,0000.0%0.00%0.0%
Q1 2018$1,752,000
-74.7%
2,000,000
-74.6%
0.00%
-75.0%
Q4 2017$6,914,000
-42.5%
7,880,000
-40.9%
0.00%
-50.0%
Q3 2017$12,016,000
-38.2%
13,333,000
-26.5%
0.01%
-42.9%
Q2 2017$19,446,000
+85.2%
18,132,000
+85.4%
0.01%
+75.0%
Q1 2017$10,502,000
+107.7%
9,781,000
+111.8%
0.01%
+100.0%
Q4 2016$5,056,000
+323.8%
4,618,000
+361.8%
0.00%
+300.0%
Q3 2016$1,193,000
-18.7%
1,000,000
-14.6%
0.00%0.0%
Q2 2016$1,467,000
-11.5%
1,171,000
-8.1%
0.00%0.0%
Q1 2016$1,657,000
+347.8%
1,274,000
+437.6%
0.00%
Q4 2015$370,000
-31.2%
237,000
-40.3%
0.00%
Q3 2015$538,000
-45.0%
397,000
-43.4%
0.00%
-100.0%
Q2 2015$979,000
-65.6%
701,000
-63.6%
0.00%
-50.0%
Q1 2015$2,850,000
+8.7%
1,926,000
+0.4%
0.00%0.0%
Q4 2014$2,621,000
-14.3%
1,919,000
-19.5%
0.00%0.0%
Q3 2014$3,059,000
+240.6%
2,383,000
+239.0%
0.00%
+100.0%
Q2 2014$898,000
-28.5%
703,000
-29.0%
0.00%0.0%
Q1 2014$1,256,000
-91.4%
990,000
-92.8%
0.00%
-90.0%
Q4 2013$14,546,000
-42.6%
13,712,000
-43.9%
0.01%
-47.4%
Q3 2013$25,326,00024,447,0000.02%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2013
NameSharesValueWeighting ↓
Western Asset Management Company, LLC 18,321,000$16,718,0009.03%
INCOME RESEARCH & MANAGEMENT 15,589,000$14,000,0006.80%
WHITEBOX ADVISORS LLC 16,000,000$14,487,0000.53%
Graham Capital Management, L.P. 16,525,000$15,005,0000.49%
ONTARIO TEACHERS PENSION PLAN BOARD 18,400,000$16,752,0000.30%
WESTWOOD HOLDINGS GROUP INC 29,005,000$26,516,0000.29%
Penn Capital Management Company, LLC 2,195,000$1,987,0000.21%
ADVENT CAPITAL MANAGEMENT /DE/ 10,000,000$9,128,0000.17%
Polar Capital LLP 20,663,000$18,813,0000.17%
RIVERHEAD CAPITAL MANAGEMENT LLC 5,000,000$4,529,0000.17%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders